Using the Inventory of Depressive Symptoms Scales (IDS-C and IDS-SR) in Clinical Research

Clinical Trials, Commercialization and HEOR, Life Sciences,
  • June 07, 2018 | (Thursday) 10am EDT (NA) / 3pm BST (UK) / 4pm CEST (EU-Central)
  • 60 min

Join our featured speakers to learn about using the Inventory of Depressive Symptoms (IDS) questionnaire in clinical research/practice to assess the severity of depressive symptoms.

Attend this webinar to:

  • Learn the rationale and methods used in developing the IDS in both clinician-rated (IDS-C) and patient self-reported (IDS-SR) formats
  • Get insights on the psychometric features of the IDS instrument and how it compares to other commonly used clinician-rated scales

The IDS was developed to make improvements on the available clinician and patient ratings by providing equivalent weightings for each symptom item; providing clearly stated anchors that estimate the frequency and severity of symptoms; including all DSM-V criterion items required to diagnose a major depressive episode; and providing matched clinician and patient ratings.

Dr. A. John Rush, the author of the health research questionnaire, will provide a brief description of the IDS and how the instrument can be used in clinical research/practice to assess depressive symptom severity. Resulting assessments can be used to screen for depression, although they have been used predominantly as measures of symptom severity.  He will also review both the rationale and methods entailed in developing the Inventory of Depressive Symptoms (IDS) in both clinician-rated (IDS-C) and self-reported (IDS-SR) formats. Psychometric features of the both the IDS-C and IDS-SR will be presented. These scales are compared to the Hamilton Rating Scale for Depression (HRS-D) in the detection of symptom change in patients with major depressive or bipolar disorder. The face validity and established psychometric features of the IDS-C and IDS-SR indicate that either may be useful in detecting symptom change, as well as in detecting residual symptoms in depressed patients.

Register today to learn more about the IDS health research instrument and how to gain access for use in clinical research or academia.

Mapi Research Trust is the official licensor and distributor of more than 300 COAs, on behalf of their developers and copyright owners. Please visit our catalog to access the complete list of COAs managed by Mapi Research Trust, or visit our website for additional information on our services to developers and copyright owners.

Speakers

A. John Rush, MD, Adjunct Professor Duke University School of Medicine, Durham NC, Adjunct Professor Texas Tech Health Sciences Center, Permian Basin TX, and CEO Curbstone Consultant LLC., Duke-NUS Medical School

Dr. Rush is the author of the Inventory of Depressive Symptoms (IDS), originally published in 1986. His research has focused on the development and testing of innovative treatments for depressive and bipolar disorders, including medications, medication combinations, somatic treatments, psychotherapy and disease management protocols. He has authored more than 800 professional publications and has received awards from the American College of Psychiatrists, American Psychopathological Association, the National Alliance for Research in Schizophrenia and Affective Disorders, the American Psychiatric Association and the Society for Biological Psychiatry, among others. He provides consultation to individuals, academic, governmental and industrial organizations in research design and academic career development.

Marie Dulac Trimoreau, Author Relations Specialist, Author Collaboration Unit, Mapi Research Trust

Marie Dulac is an Author Relations Specialist who manages health research questionnaire distribution and licensing for Mapi Research Trust.

Who Should Attend?

Senior professionals involved in:

  • Clinical research
  • Academic research
  • Health Economics & Outcomes Research (HEOR)

What You Will Learn

  • How to use the Inventory of Depressive Symptoms (IDS) questionnaire in clinical research/practice to assess the severity of depressive symptoms
  • Learn the rationale and methods used in developing the IDS in both clinician-rated (IDS-C) and patient self-reported (IDS-SR) formats
  • Get insights on the psychometric features of the IDS instrument and how it compares to other commonly used clinician-rated scales

Xtalks Partners

Mapi Research Trust

Mapi Research Trust is a non-profit organization dedicated to improving patients’ quality of life by facilitating access to Patient-Centered Outcome (PCO) information. Mapi Research Trust promotes scientific approaches in the PCO field and encourages exchanges between academics, pharmaceutical companies, and international organisations around the world in the service of incorporating the patient’s voice into every step of the development process of new treatments. For nearly two decades Mapi Research Trust has been a direct contributor to nearly every translational science research program incorporating PCO. We offer free and subsidized access to thousands of independent and academic research programs in over 130 countries every year. In this manner Mapi Research Trust contributes some 4 M€ a year in services that support academic research focusing on the improvement of patients’ lives.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account